Increasing Serum Complement Component 1q is Associated with Worse Prognosis in Advanced Non-Small Cell Lung Cancer Treated with Immune Checkpoint Inhibitors: a Single-Center, Retrospective Study

Jiazhuo Tang,Yang Fu,Yuxiao Song,Jiaxin Yin,Jun Wang,Hugo Arasanz,Bicheng Zhang

Journal of Thoracic Disease（2024）

引用 2|浏览12

关键词

Complement component 1q (C1q),non-small cell lung cancer (NSCLC),immune checkpoint inhibitors (ICIs),survival,Eastern Cooperative Oncology Group performance status (ECOG-PS)

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要